| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 187,769 | 126,686 | 79,621 | | Cost of Revenue | 69,561 | 50,243 | 32,100 | | | Gross Profit | 118,208 | 76,443 | 47,521 | | | Operating Expenses | | Research Development | 32,557 | 23,880 | 18,037 | | Selling General and Administrative | 73,062 | 52,160 | 37,735 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 12,589 | 403 | (8,251) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,550 | 3,269 | 1,041 | | Earnings Before Interest And Taxes | 16,139 | 3,672 | (7,210) | | Interest Expense | 40 | 717 | 765 | | Income Before Tax | 16,099 | 2,955 | (7,975) | | Income Tax Expense | (15,420) | 961 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 31,519 | 1,994 | (7,975) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 31,519 | 1,994 | (7,975) | | Preferred Stock And Other Adjustments |
-
| (2,853) | (5,931) | | | Net Income Applicable To Common Shares | $31,519 | ($859) | ($13,906) |
|
0.49% Nasdaq 
0.14 (1.49%) 
Income Statement
